The prevalence of potential drug-drug interactions in adults with intellectual disability

McMahon, Martin and Hatton, Chris and Bowring, Darren Lee and Hardy, Claire and Preston, Nancy (2021) The prevalence of potential drug-drug interactions in adults with intellectual disability. Journal of Intellectual Disability Research, 65 (10). pp. 930-940. ISSN 0964-2633

[thumbnail of Accepted_version_Drug_drug_JIRD]
Text (Accepted_version_Drug_drug_JIRD)
Accepted_version_Drug_drug_JIRD.pdf - Accepted Version
Available under License Creative Commons Attribution-NonCommercial.

Download (303kB)


Background There is a high use of medications in adults with intellectual disability (ID). One implication of taking multiple medications is the potential for drug–drug interactions (DDIs). However, despite this being well highlighted in the mainstream literature, little is known about the incidence or associations of DDIs in the ID population. Methods This study describes the prevalence, patterns and associations of potential DDIs in a total administrative sample of adults with ID known to services in Jersey. Demographic, health‐related and medication data were collected from 217 adults known to ID services. Data were collected using a face‐to‐face survey. The Anatomical Therapeutic Chemical classification system was used to categorise medications, and Stockley's Drug Interaction Checker was used to classify potential DDIs. Drug–drug pairings were considered to be of clinical significance if they were to be ‘avoided, adjusted, monitored or required further information’. Results Potential DDIs of clinical significance were common. Exposure to potential DDIs of clinical significance was associated with being female, taking more than five medications (polypharmacy), living in residential care and having more health conditions. A simple regression was used to understand the effect of number of prescribed medications on potential DDIs of clinical significance. Every prescribed drug led to a 0.87 (95% confidence interval: 0.72–1.00) increase in having a potential DDI of clinical significance. Conclusion Adults with ID who live in residential care, who are female, exposed to polypharmacy and have more health conditions may be more likely to have potential DDIs of clinical significance. Urgent consideration needs to be given to the potential of DDIs in this population given their exposure to high levels of medication.

Item Type:
Journal Article
Journal or Publication Title:
Journal of Intellectual Disability Research
Additional Information:
This is the peer reviewed version of the following article:McMahon, M., McMahon, M., Hatton, C., Bowring, D. L., Hardy, C., and Preston, N. J. (2021) The prevalence of potential drug–drug interactions in adults with intellectual disability. Journal of Intellectual Disability Research, 65: 930– 940. which has been published in final form at This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Uncontrolled Keywords:
?? adverse reactiondrug–drug interactionintellectual disabilitymedicationpolypharmacyclinical neurologyrehabilitationpsychiatry and mental healthneurology ??
ID Code:
Deposited By:
Deposited On:
18 May 2021 08:58
Last Modified:
17 Dec 2023 01:52